Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: LncRNA WEE2-AS1 is a diagnostic biomarker that predicts poor prognoses in patients with glioma

Fig. 3

The relationship between WEE2-AS1 and the survival of patients with glioma

(A)–(C) Kaplan–Meier survival analysis showing that effect of WEE2-AS1 expression level on overall survival (OS) (A), progression-free interval (PFI) (B), and disease-specific survival (DSS) (C) in patients with glioma in TCGA cohort. (D) Nomogram for predicting the probability of 1-, 3-, and 5-year OS for patients with glioma. (E) Calibration plot of the nomogram for predicting the probability of OS at 1, 3, and 5 years. The abscissa is the probability of the prognosis predicted by the model (0–1 indicates that the probability of the event occurring is 0–100%) and the ordinate is the actually observed prognosis. The colored line is the fitted line indicating the predicted value (the horizontal axis) corresponding to the actual value (the vertical axis). The gray diagonal is the ideal case

Back to article page